WHO Halts Hydroxychloroquine Trial Over Safety Concerns
The WHO cited a scientific study published last week suggesting that proposed COVID-19 drug hydroxychloroqine may do more harm than good in halting its study to review data.
Full Article
WHO Halts Hydroxychloroquine Trial Over Safety Concerns
NPR
0 shares
1 views
You might like
Related news coverage
Germany pauses anti-malaria drug study for COVID-19: Spiegel
Reuters India
A university in Germany has suspended a clinical study using the anti-malaria drug hydroxychloroquine for COVID-19, Spiegel Online..
-
British regulator says 'COPCOV' hydroxychloroquine trial paused
Reuters India
-
France bans controversial drug to treat COVID-19
Brisbane Times
-
WHO expects hydroxychloroquine safety findings by mid-June
Reuters India
-
WHO says hydroxychloroquine safety findings expected by mid-June
Reuters India
Advertisement
More coverage
WHO Suspends Hydroxychloroquine Trial Over Safety Concerns
Newsy
Watch VideoThe World Health Organization said it's going to temporarily suspend testing on hydroxychloroquine as a potential..
-
WHO pauses trial of hydroxychloroquine, once touted by Trump as a ‘game changer,’ over safety concerns
Seattle Times
-
WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns
Reuters India
-
COVID-19: WHO suspends trial of hydroxychloroquine over safety concerns
Premium Times Nigeria
-
News24.com | WHO suspends trial of hydroxychloroquine as Covid-19 treatment over safety concerns
News24